Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Idiopathic intracranial hypertension associated with anaemia, secondary to antiretroviral drug in a human immunodeficiency virus positive patient.

Ananth JV, Sudharshan S, Selvakumar A, Devaleenal BJ, Kalaivani K, Biswas J.

Indian J Ophthalmol. 2018 Jan;66(1):168-169. doi: 10.4103/ijo.IJO_592_17.

2.

Nuclear magnetic resonance study of obsessive-compulsive disorder.

Garber HJ, Ananth JV, Chiu LC, Griswold VJ, Oldendorf WH.

Am J Psychiatry. 1989 Aug;146(8):1001-5.

PMID:
2750970
3.

The use of nicotinic acid and pyridoxine in the treatment of schizophrenia.

Petrie WM, Ban TA, Ananth JV.

Int Pharmacopsychiatry. 1981;16(4):245-50.

PMID:
7040274
4.

Conditioning and the classification of the chronic schizophrenic patient.

Ban TA, Ananth JV, Lehmann HE.

Pavlov J Biol Sci. 1979 Jan-Mar;14(1):44-60.

PMID:
537842
5.

An uncontrolled study with thiopropazate in the treatment of persistent dyskinesia.

Ananth JV, Ban TA, Lehmann HE.

Psychopharmacol Bull. 1977 Jul;13(3):9. No abstract available.

PMID:
329332
6.

Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: a placebo-controlled clinical study.

Deutsch M, Ananth JV, Ban TA.

Psychopharmacol Bull. 1977 Jul;13(3):21-3. No abstract available.

PMID:
142260
7.

A standard-controlled clinical study with propericiazine in schizophrenic patients.

Ananth JV, Ban TA.

Psychopharmacol Bull. 1977 Jul;13(3):19-20. No abstract available.

PMID:
18754
8.

Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--I. Report on an uncontrolled clinical trial.

Campbell P, Ananth JV, Gomez L.

Psychopharmacol Bull. 1976 Jan;12(1):23-4. No abstract available.

PMID:
1108077
9.

A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients.

Jain RC, Ananth JV, Lehmann HE, Ban TA.

Curr Ther Res Clin Exp. 1975 Oct;18(4):585-9. No abstract available.

PMID:
241609
10.

Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.

Ban TA, Ananth JV, Lehmann HE.

Act Nerv Super (Praha). 1974 Mar;16(1):23-33. No abstract available.

PMID:
4156144
11.

Exacerbation of psychopathology during treatment: etiology.

Ananth JV.

Compr Psychiatry. 1973 Nov-Dec;14(6):563-8. No abstract available.

PMID:
4764356
12.

Benztropine psychosis.

Ananth JV, Jain RC.

Can Psychiatr Assoc J. 1973 Oct;18(5):409-14. No abstract available.

PMID:
4746144
13.

Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics.

Ananth JV, Ban TA, Lehmann HE.

Can Psychiatr Assoc J. 1973 Oct;18(5):377-83. No abstract available.

PMID:
4147710
14.

Treatment of psychosis subsequent to phenothiazine-induced agranulocytosis.

Ananth JV, Beszterczey A.

Compr Psychiatry. 1973 Jul-Aug;14(4):319-23. No abstract available.

PMID:
4146801
15.

An uncontrolled clinical trial with clomipramine in the treatment of depressed patients.

Campbell P, Gomez L, Ananth JV, Bronheim LA, Klingner A, Ban TA.

Curr Ther Res Clin Exp. 1973 Apr;15(4):223-31. No abstract available.

PMID:
4633284
16.

Diazepam in the treatment of insomnia in psychiatric patients.

Ananth JV, Bronheim LA, Klingner A, Ban TA.

Curr Ther Res Clin Exp. 1973 Apr;15(4):217-22. No abstract available.

PMID:
4633283
17.

Chlorpromazine-induced systemic lupus erythematosus.

Ananth JV, Minn K.

Can Med Assoc J. 1973 Mar 17;108(6):680. No abstract available.

18.

Uncontrolled study with pipothiazine palmitate.

Jain RC, Ananth JV, Klingner A, Ban TA, Lehmann HE.

Int J Clin Pharmacol. 1973 Feb;7(1):32-6. No abstract available.

PMID:
4699381
19.

Usual and unusual agranulocytosis during neuroleptic therapy.

Ananth JV, Valles JV, Whitelaw JP.

Am J Psychiatry. 1973 Jan;130(1):100-2. No abstract available.

PMID:
4405009
20.

Conditioned reflex analysis of chronic schizophrenias.

Ananth JV, Lehman HE, Ban TA.

Can Psychiatr Assoc J. 1972 Oct;17(5):377-89. No abstract available.

PMID:
4644786
21.

The use of methyldopa in schizophrenia: a review and comparative study.

Pecknold JC, Ananth JV, Ban TA, Lehmann HE.

Am J Psychiatry. 1972 Apr;128(10):1207-11. No abstract available.

PMID:
5013737
22.

Propericiazine in psychiatric emergencies. A controlled comparative study.

Ananth JV, Salib M, Ban TA, Lehmann HE.

Can Psychiatr Assoc J. 1972 Apr;17(2):143-5. No abstract available.

PMID:
4402542
23.

Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study.

Ananth JV, Vacaflor L, Kekhwa G, Sterlin C, Ban TA.

Int Z Klin Pharmakol Ther Toxikol. 1972 Feb;5(4):406-10. No abstract available.

PMID:
4261601
24.

Test-retest performance in chronic schizophrenia on the Verdun Conditioning Program.

Ananth JV, Ban TA, Lehmann HE.

Can Psychiatr Assoc J. 1972;17(2):Suppl 2:SS227. No abstract available.

PMID:
5042902
25.

Repeated episodes of phenmetrazine psychosis.

Ananth JV.

Can Med Assoc J. 1971 Dec 18;105(12):1280-1. No abstract available.

26.

Troxonium tosylate in drug-induced Parkinsonism: a controlled comparative study.

Pecknold JC, Ananth JV, Ban TA, Lehmann HE.

J Clin Pharmacol New Drugs. 1971 Sep-Oct;11(5):367-70. No abstract available.

PMID:
4998432
27.

Lack of indication for use of antiparkinson medication. A follow-up study.

Pecknold JC, Ananth JV, Ban TA, Lehmann HE.

Dis Nerv Syst. 1971 Aug;32(8):538-41. No abstract available.

PMID:
5094160
28.

Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function.

Leckman J, Ananth JV, Ban TA, Lehmann HE.

J Clin Pharmacol New Drugs. 1971 Jul-Aug;11(4):301-3. No abstract available.

PMID:
4932747
29.

A clinical study with propericiazine in chronic psychotic patients.

Deutsch M, Ananth JV, Ban TA.

Curr Ther Res Clin Exp. 1971 Jun;13(6):353-8. No abstract available.

PMID:
4397391
30.

Senilex in the treatment of geriatric patients.

Ananth JV, Deutsch M, Ban TA.

Curr Ther Res Clin Exp. 1971 May;13(5):316-21. No abstract available.

PMID:
4998395
31.

An adverse reaction unit: results and functions.

Ananth JV, Ban TA, Lehmann HE, Rizvi FA.

Am J Psychiatry. 1971 Apr;127(10):1339-44. No abstract available.

PMID:
5092571
32.

Troxonium tosylate in the treatment of drug-induced extrapyramidal manifestations.

Koh CV, Ananth JV, Ban TA, Lehmann HE.

Int Z Klin Pharmakol Ther Toxikol. 1971 Apr;4(3):289-91. No abstract available.

PMID:
4931413
33.

Combined administration of thioridazine and nicotinic acid in the treatment of geriatric patients.

Ananth JV, Saxena BM, Lehmann HE, Ban TA.

Curr Ther Res Clin Exp. 1971 Mar;13(3):158-61. No abstract available.

PMID:
4998286
34.

Urinary incontinence associated with thioridazine administration.

Ananth JV, Ban TA, Lehmann HE.

Can Med Assoc J. 1971 Feb 20;104(4):326 passim. No abstract available.

35.

Complications of psychotropic medications in high dosage.

Warnes H, Ananth JV.

Psychiatr Q. 1971;45(1):87-91. No abstract available.

PMID:
5120056
36.

Treatment of depression with dexedrine and demerol.

Lehmann HE, Ananth JV, Geagea KC, Ban TA.

Curr Ther Res Clin Exp. 1971 Jan;13(1):42-9. No abstract available.

PMID:
4992565
37.

Tolbutamide jundice associated with multiple drug therapy.

Ananth JV, Ban TA, Lehmann HE.

Can Med Assoc J. 1970 Nov 21;103(11):1194. No abstract available.

38.

Toxic psychosis induced by benzhexol hydrochloride.

Ananth JV.

Can Med Assoc J. 1970 Oct 10;103(7):771. No abstract available.

39.

Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients.

Ananth JV, Horodesky S, Lehmann HE, Ban TA.

Laval Med. 1970 Sep;41(7):934-8. No abstract available.

PMID:
5509491
40.

Fluspirilene in the treatment of chronic schizophrenic patients.

Chouinard G, Ban TA, Lehmann HE, Ananth JV.

Curr Ther Res Clin Exp. 1970 Sep;12(9):604-8. No abstract available.

PMID:
4989692
41.

Agranulocytosis associated with methotrimeprazine (Nozinan) administration: a report of three cases.

Ananth JV, Lehmann HE, Ban TA.

Can Med Assoc J. 1970 Jun 6;102(12):1286-7. No abstract available.

42.

CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.

Villeneuve C, Ananth JV, Ban TA, Lehmann HE.

Curr Ther Res Clin Exp. 1970 Apr;12(4):223-9. No abstract available.

PMID:
4985943
43.

Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenics.

Ananth JV, Ban TA, Lehmann HE, Bennett J.

Can Psychiatr Assoc J. 1970 Feb;15(1):15-20. No abstract available.

PMID:
4906138
44.

Night center.

Ananth JV.

Psychiatr Q. 1968;42(2):Suppl:252-7. No abstract available.

PMID:
5747999

Supplemental Content

Loading ...
Support Center